title: [Levofloxacin-related Stevens-Johnson syndrome].
authors.forename: O
authors.initials: O
authors.lastname: Fernández Arenas
authors.forename: E
authors.initials: E
authors.lastname: López Lunar
authors.forename: M
authors.initials: M
authors.lastname: Gutiérrez García
authors.forename: F J
authors.initials: FJ
authors.lastname: Hidalgo Correas
authors.forename: B
authors.initials: B
authors.lastname: García Díaz
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D055499:Catheter-Related Infections / Q000150:complications / Q000188:drug therapy; D003354:Corynebacterium Infections / Q000150:complications / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D064704:Levofloxacin; D008775:Methylprednisolone / Q000627:therapeutic use; D015242:Ofloxacin / Q000009:adverse effects* / Q000627:therapeutic use; D010289:Parenteral Nutrition, Total; D012074:Remission Induction; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000150:complications / Q000188:drug therapy; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy; D015163:Superinfection
chemical_list: D000900:Anti-Bacterial Agents; D064704:Levofloxacin; D015242:Ofloxacin; D008775:Methylprednisolone